3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Carcinoma, Renal Cell
4
Urinary Bladder Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
2
Ovarian Neoplasms
2
Kidney Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uterine Cervical Neoplasms
1
Urothelial Bladder Carcinoma
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Prostatic Neoplasms, Castration-Resistant
1
Prostatic Neoplasms
1
Oligometastatic Prostate Cancer
1
Neoplasms
1
Neoplasm Metastasis
1
Metastatic Urothelial Cancer
1
Melanoma
1
Esophageal Neoplasms
1
Erythrocytosis, Familial, 4
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Carcinoma, Transitional Cell
1
Carcinoma, Merkel Cell
1
Breast Neoplasms
1
Interventions
Androgen Antagonists
3
Radiosurgery
2
zimberelimab
1
quemliclustat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Oligometastatic Prostate Cancer
×
zimberelimab
×
Genitourinary
×
Clear all
NCT05915442
2025-05-20
SBRT-AMICO
Columbia University
Phase 2
Recruiting
23 enrolled